Helmut Butzkueven

Professor

Professor (Research), Department of Neuroscience

https://orcid.org/0000-0003-3940-8727

Phone03 90762059
EmailHelmut.Butzkueven@monash.edu
Websitehttps://www.monash.edu/medicine/ccs/neuroscience/research/butzkueven-group

Accepting PhD Students

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Professor Helmut Butzkueven

Department of Neuroscience research groups - Butzkueven Lab

Helmut Butzkueven is Professor of Neurology and Chair of Multiple Sclerosis and Neuroimmunology research in the Department of Neuroscience, Central Clinical School.

Professor Butzkueven is Head of Multiple Sclerosis and Neuroimmunology at the Alfred Hospital and Director of the MS service at Box Hill Hospital, Melbourne, Australia. He is Managing Director of the MSBase Foundation (www.msbase.org) that funds and administers a global online MS cohort study with more than 70000 patients enrolled in 130 centres across 27 countries.

His overarching research theme and clinical interest is the use of registry data, clinical MRI data, cognitive testing, genomics and patient self-monitoring devices and applications to evaluate treatment strategies to optimize benefit and safety of MS therapies.

Research area keywords

Multiple Sclerosis (MS)
Clinical Outcomes
Participatory research
Pharmacogenomics
vitamin D
e-health

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

12 Active
13 Finished

Active self-monitoring to prospectively detect treatment failure and define subclinical progression trajectories in multiple sclerosis: The ACTIVE-MS Program.

Van Der Walt, A., Butzkueven, H., Jokubaitis, V., Kolbe, S., Vogel, A. P., Stankovich, J., Butler, E., Macdonell, R. A. L. & Darby, D.

Trish Multiple Sclerosis Research Foundation

1/01/20 → 31/12/22

Project: Research

Collaboration on Roche Managed Primary Data Collection NIS and RWD Analytics Activities

Butzkueven, H. & Van Der Walt, A.

Hoffmann-La Roche

6/12/19 → 1/12/26

Project: Research

Monash-Roche Meaningful Data at Scale Collaboration for MS

Van Der Walt, A. & Butzkueven, H.

Hoffmann-La Roche

6/12/19 → 31/12/27

Project: Research

Pharmacogenomic prediction of treatment response in multiple sclerosis

Van Der Walt, A., Jokubaitis, V. & Butzkueven, H.

21/10/19 → 20/04/20

Project: Research

Analysis of Real-World Long-Term Effectiveness of Ocrelizumab in Primary Progressive MS Disease

Butzkueven, H. & Hinson, E.

11/09/19 → 30/11/23

Project: Research

Research Output

174 Article
19 Review Article
8 Letter
2 Conference Paper
8 More

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

Kunchok, A., Malpas, C., Nytrova, P., Havrdova, E. K., Alroughani, R., Terzi, M., Yamout, B., Hor, J. Y., Karabudak, R., Boz, C., Ozakbas, S., Olascoaga, J., Simo, M., Granella, F., Patti, F., McCombe, P., Csepany, T., Singhal, B., Bergamaschi, R., Fragoso, Y. & 21 others, Al-Harbi, T., Turkoglu, R., Lechner-Scott, J., Laureys, G., Oreja-Guevara, C., Pucci, E., Sola, P., Ferraro, D., Altintas, A., Soysal, A., Vucic, S., Grand'Maison, F., Izquierdo, G., Eichau, S., Lugaresi, A., Onofrj, M., Trojano, M., Marriott, M., Butzkueven, H., Kister, I. & Kalincik, T., 1 Feb 2020, In : Multiple Sclerosis and Related Disorders. 38, 8 p., 101868.